Inhibition of tryptophan - Pyrrolase activity and elevation of brain tryptophan concentration by fluoxetine in rats

Journal of the College of Physicians and Surgeons Pakistan

Volumn 13, Issue 1, 2003, Pages 5-10

  Bano, Samina ^a   Sherkheli, Muhammad Azhar ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

Author keywords

Fluoxetine; Tryptophan brain; Tryptophan pyrrolase

Indexed keywords

ALBUMIN; APOENZYME; FATTY ACID; FLUOXETINE; GLUCOSE; HEME; SEROTONIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; BODY WEIGHT; CLINICAL RESEARCH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LIVER LEVEL; MALE; NONHUMAN; PAKISTAN; PROTEIN SYNTHESIS; RAT; RAT STRAIN; TRYPTOPHAN BRAIN LEVEL; TRYPTOPHAN METABOLISM;

ANIMALS; BRAIN; BRAIN CHEMISTRY; FLUOXETINE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LIVER; MALE; RATS; RATS, WISTAR; TRYPTOPHAN; TRYPTOPHAN OXYGENASE;

EID: 0037260529     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. 2 sites in cortex and amygdale. Brain Res 1993; 614 :37-44.
2. Meltzer HY, Lowy MT. The serotonin hypothesis of depression. Meltzer HY, (edi). Pharmacology: the third generation of progress, New York: Raven Press 1987; 513-26.
3. Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ. Evidence for the 5-HT-hypothesis of suicide: a review of postmortem studies. Br J Psychiatry Suppl 1989; 8: 7-14.
4. Cooper SJ, Kelley CB, King DJ. 5-Hydroxyindole acetic acid in cerebrospinal fluid and prediction of suicidal behavior in schizophrenia. Lancet 1992; 340: 940-1.
5. Cowen P, Parry-billings M, Newsholme EA. Decreased plasma tryptophan levels in major depression. J Affect Disord 1989; 16: 27-31.
6. Blier P, de Montiogny C, Chaput Y. Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT. Neurotransm mission. Clin Neuropharmacol 1988; 11 (suppl 2): S1-S10.
7. Young SN, Pihl RO, Ervin FR. The effects of altered tryptophan levels on mood and behavior in normal human males. Clin Neuropharmacol 1988; (11 suppl): S207-S15.
8. Delgado PL, Charney DS, Price LH, Aghajanian GK, Landish H, Heninger GR. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 1990; 47: 411-8.
9. Moreno FA, Heninger GR, Mcgahuey CA, Delgado PL. Tryptophan depletion and risk of depression relapse: a prospective study of tryptophan depletion as a potential predictor of depression episodes. Biol Psychiatry 2000; 48: 327-9.
10. Curzon G. Serotonergic mechanism of depression. Clin Neuropharmacol 1988; 11: 511-20.
11. Maes MS, Scharpe C, Martin S, Blocky P. The effects of glucocorticoids on the availability of tryptophan and tyrosine in the plasma of depressed patients. J Affect Disord 1990; 18: 21-8.
12. Nemeroff CB. The neurobiology of depression. Sci Am 1998; 278: 42-9.
13. Maes M, Meltzer HY, Scharpe S, Bosmans E, Suy E, De Meester I, et al. Relationships between lower plasma L-tryptophan levels and immune inflammatory variables in depression. Psychiatry Res 1993; 49: 151-65.
14. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 1971; 173: 149-52.
15. Curzon G, Knott PJ. Effects on plasma and brain tryptophan in the rat of drugs and hormones that influence the concentration of non-estrified fatty acids. Br J Pharmacol 1974; 50: 197-204.
16. Badawy AAB. The functions and regulation of tryptophan pyrrolase. Life Sci 1977; 21: 755-68.
17. Badawy AA, Evans M. Further evidence against inhibition of synthesis of rat liver tryptophan pyrrolase by chronic ethanol administration. Br J Alcohol Alcoholism 1979; 14: 59-64.
18. Rizvani AH, Overstreet DH, Mason GA, Janowsky DS, Hamedi M, Clark EJ, et al. Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol preferring rats. Alcohol Alcohol 2000; 35: 76-83.
19. Jackson HC, Needham AM, Hutchins LJ, Mazurkiewicz SE, Heal DJ. Comparison of the effects of sibutramine and other monoamine re-uptake inhibitors on food in takes in rat. Br J Pharmacol 1997; 121: 1758-62.
20. Tauscher J, Pirker W, de Zwaan M, Asenbaum S, Brucke T, Kasper S. In vivo visualization of serotonin transporters in the human brain during fluoxetine treatment. Eur Neuropsychopharmacol 1999; 9: 177-9.
21. Pirker W, Asenbaum S, Kasper S, Walter H, Angel Berger P, Koch G, et al. Beta CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo. J Neural Transm Gen Sect 1995; 100: 247-56.
22. Bano S, Morgan CJ, Badawy AAB, Buckland PR, McGuffin P. Inhibition of rats liver tryptophan pyrrolase activity by fluoxetine. Pakistan J Pharmaceut Sci 1999; 12: 11-6.
23. Bano S, Toor M, Morgan CJ, Badawy AAB, Buckland P, McGuffin P. Inhibition of rat liver tryptophan pyrrolase activity by acamprosate, moclobamide, roxindole, SSRI's and tianeptine. J Psychopharmacol 1995; 9(suppl): A23.
24. Badawy AAB, Evans M. The regulation of rat liver tryptophan pyrrolase by its cofactor haem-experiments with haematin and 5-aminolaevulinate and comparison with substrate and hormonal mechanisms. Biochem J 1975; 150: 511-20.
25. Badawy AAB, Evans M. Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by administration of antidepressants. Biochem Pharmacol 1981; 30: 1211-6.
26. Badawy AAB, Morgan CJ, Davis NR. Determination of liver tryptophan pyrrolase activity in rat liver homogenates. Biochem J 1983; 215: 709-10.
27. Bloxam DL, Warren WH. Error in the determination of tryptophan in the method of Denkla and Dewey: a revised procedure. Anal Biochem 1974; 60: 621-5.
28. Curzon G, Green AR. Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. Br J Pharmacol 1970; 39: 653-5.
29. Doumas BT, Biggs HT. Determination of serum albumin. Standard Methods In Clin chem 1972; 7: 175-88.
30. Mikec-Devic D, Stankovic H, Boskovic K. A method for determination of free fatty acids in serum. Clin Chim Acta 1973; 45: 55-9.
31. Hultmann E. Estimation of glucose by o-toludine. Nature 1959; 183: 108.
32. Badawy AAB, Morgan CJ, Bano S, Buckland P, McGuffin P. Mechanism of enhancement of rat brain serotonin synthesis by acute fluoxetine administration. J Neurochem 1996; 66: 436-7.
33. Badawy AAB, Evans M. Inhibition of rat liver tryptophan pyrrolase activity and elevation of brain tryptophan concentration by acute administration of small doses of antidepressants. Br J Pharmacol 1982; 77: 059-067.
34. Tsuiki K, Yamamoto YL, Diksic M. Effects of acute fluoxetine treatment on the brain serotonin synthesis as measured by the alpha-methyl-L-tryptophan auto radiographic method. J Neurochem 1995; 65:250-6.
35. Muck-Seler D, Jevric-Causevic A, Diksic M. Influence of fluoxetine on regional serotonin synthesis in the rat brain. J Neurochem 1996; 67: 2434-42.
36. Salter M, Hazelwood R, Pogson CI, Iyer R, Madge DJ, Jones HT, et al. The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan-2,3-dioxygenase and 5-HT reuptake in the rat. Neuropharmacol 1995; 34: 217-27.
37. Koyama T, Meltzer HY. A biochemical and neuroendocrine study of the serotonergic system in depression. In: Hippius H, (edi). New results in depression research. Berlin-Heidelberg: Springer-Verlag 1986; 169-88.
38. Deakin JF, Pennell I, Upadhyaya AJ, Lofthouse R. A neuroendocrine study of 5-HT function in depression: evidence for biological mechanisms of endogenous and psychosocial causation. Psychopharmacol 1990; 101: 85-92.
39. Salter M, Pogson CI. The role of tryptophan (2, 3) dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Biochem J 1985; 229: 499-504.
40. Maes M, de Ruyter M, Claes R, Bosma G, Suy E. The cortisol responses to 5-hydroxytryptophan, orally, in depressive patients. J Affect Disord 1987a; 13: 23-30.
41. Maes M, de Ruyter M, Suy E. The renal excretion of xanthurenic acid following L-tryptophan loading in depressed patients. Human Psychopharmacol 1987b; 231-35.
42. Young SN, Smith SE, Phil RO, Ervin FR. Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacol 1985; 87: 173-77.